'My aunt used a weight loss jab and died'
It was only in August when 58-year-old nurse Susan McGowan took two low-dose injections of the NHS-approved weight loss drug Tirzepatide. However, just 2 weeks into administering them, Susan tragically passed away, with her death certificate being the first to officially link the drug to a death in the UK. Her niece Jade, speaks about her aunt's life raising awareness, alongside bariatric surgeon Shaw Somers.
The MHRA Chief Safety Officer Dr Alison Cave said: “Patient safety is our top priority. No medicine would be approved unless it met our expected standards. New medicines are more intensively monitored to ensure that any new safety issues are identified promptly. We encourage patients and healthcare professionals to continue reporting suspected side effects through our Yellow Card Scheme. When a safety issue is confirmed, we always act promptly.”Mounjaro's maker, Lilly said: “Patient safety is Lilly’s top priority. We are committed to continually monitoring, evaluating, and reporting safety information for all Lilly medicines. We provide information about the benefits and risks of all our medicines to regulators to ensure the latest information is available for prescribers. If anyone is experiencing side effects they should talk to their doctor or healthcare professional.”